SAFEGUARDS AGAINST OTC ZOVIRAX MISUSE
This article was originally published in The Tan Sheet
Executive Summary
SAFEGUARDS AGAINST OTC ZOVIRAX MISUSE will include specific, "easy-to-read" instructions that inform consumers of the signs and symptoms of genital herpes and that stress the "importance of appropriate continuing medical attention," Burroughs Wellcome Senior Clinical Research Scientist Gray Davis, PhD, told an FDA public hearing on the proposed Rx-to-OTC switch. Patients also will be "warned" in product labeling "not to use the medication for any purpose" other than for genital herpes, Davis said.
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning